Prostate Cancer

September is Prostate Cancer Awareness Month and the Department of Radiology and Biomedical Imaging is at the forefront of research to understand prostate cancer and develop treatments. These are just a few of the publications this year by our researchers.

Congrats to Anil Bidkar, PhD, a postdoctoral scholar in Robert Flavell’s Molecular Imaging Lab who has been awarded the NIH Pathway to Independence Award (K99/R00) from the National Cancer Institute. Bidkar’s research focuses on developing next-generation targeted therapies for metastatic castration-resistant prostate cancer (mCRPC).

“Great science, great technology, great thinking, and great connectivity can change the world,” said Charles J. Ryan, MD, CEO of the Prostate Cancer Foundation, as he welcomed the world’s leading experts in prostate cancer care to the inaugural PSMA Conference, held at University of California, San Francisco, January 18-19, 2024.

The National Institute of Health’s (NIH) National Institute on Minority Health and Health Disparities (NIMHD) awards diversity supplements to increase diversity in the research.

An article in the Journal of Nuclear Medicine reports findings of a multi-center retrospective study that compares bone scan with PSMA PET for initial staging of prostate cancer. Authors include UCSF Radiology and Biomedical Imaging faculty members Thomas Hope, MD, Roxanna Juarez, MD, Miguel Hernandez Pampaloni, MD, PhD, and clinical research coordinator Daniel Thompson.

We are excited to announce the first annual PSMA Conference, “PSMA PET and RLT: Present and Future.” The conference will take place online and in-person in San Francisco on January 18-19, 2024. Registration for in-person and virtual attendance is now open. In-person attendees who register by October 1 will save $100 on the enrollment fee!

Kondapa Naidu Bobba, PhD, is first author of "Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair For 225Ac -Radiotherapeutics," a Journal of Nuclear Medicine (JNM) article published May 18 that discusses the development of a robust radiolabeling methodology and applied optimized method for utilizing prostate cancer targeting agents PSMA-617 and antibody YS5.

Three UCSF Radiology researchers have received Surbeck Travel Awards to present their research at the International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting. The recipients — Matthew Gibbons, PhD, Céline Taglang, PhD, and Pierre Nedelec — will travel to Toronto for the conference taking place June 3-8, 2023.

Each Surbeck Travel Award recipient will give an oral presentation at ISMRM

https://cdmrp.health.mil/funding/pcrp.aspxAnil Bidkar, PhD, has received the Department of Defense (DoD) Prostate Cancer Research Program (PCRP) Early Investigator Research Award.

Beyond PSMA: CD46 Targeted 225Ac Alpha Particle Radioimmunotherapy for Prostate Cancer